Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Goldberg

Showing results (981-990 of 1,197) with videos related to

Pageof 120
Sort By:
Journal of Dental Research|July 2, 2015
Mechanical Forces Exacerbate Periodontal Defects in Bsp-null MiceY Soenjaya, B L Foster, F H Nociti, et al.
Surgery|April 1, 1986
Continuous hepatic artery infusion with an implantable pump: problems with hepatic artery anomaliesM M Kemeny, J M Hogan, D A Goldberg, et al.
Nuclear Medicine Communications|December 1, 1987
Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin IIJ A Goldberg, M S Bradnam, D J Kerr, et al.
Ophthalmic Plastic and Reconstructive Surgery|November 16, 2011
Histopathology of brow fat in thyroid-associated orbitopathyCatherine J Hwang, Nicole M Khadavi, Konstantinos Papageorgiou, et al.
Circulation Research|May 1, 1995
Regulation of vascular endothelial growth factor in cardiac myocytesA P Levy, N S Levy, J Loscalzo, et al.
British Journal of Cancer|July 1, 1991
Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastasesJ A Goldberg, J A Thomson, M S Bradnam, et al.
Anti-Cancer Drugs|July 1, 1996
A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918V K Malviya, P Y Liu, D A Goldberg, et al.
Neurology|December 1, 1996
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study GroupL J Thal, G Schwartz, M Sano, et al.
The Journal of Biological Chemistry|September 24, 2011
Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survivalNatsuko Tanabe, Benjamin D Wheal, Jiyun Kwon, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 20, 2011
Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancerLaura M Lashinger, Lauren M Malone, Graham W Brown, et al.
Pageof 120

Showing results (981-990 of 1,197) with videos related to

Sort By:
Pageof 120
Journal of Dental Research|July 2, 2015
Mechanical Forces Exacerbate Periodontal Defects in Bsp-null MiceY Soenjaya, B L Foster, F H Nociti, et al.
Surgery|April 1, 1986
Continuous hepatic artery infusion with an implantable pump: problems with hepatic artery anomaliesM M Kemeny, J M Hogan, D A Goldberg, et al.
Nuclear Medicine Communications|December 1, 1987
Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin IIJ A Goldberg, M S Bradnam, D J Kerr, et al.
Ophthalmic Plastic and Reconstructive Surgery|November 16, 2011
Histopathology of brow fat in thyroid-associated orbitopathyCatherine J Hwang, Nicole M Khadavi, Konstantinos Papageorgiou, et al.
Circulation Research|May 1, 1995
Regulation of vascular endothelial growth factor in cardiac myocytesA P Levy, N S Levy, J Loscalzo, et al.
British Journal of Cancer|July 1, 1991
Angiotensin II as a potential method of targeting cytotoxic-loaded microspheres in patients with colorectal liver metastasesJ A Goldberg, J A Thomson, M S Bradnam, et al.
Anti-Cancer Drugs|July 1, 1996
A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918V K Malviya, P Y Liu, D A Goldberg, et al.
Neurology|December 1, 1996
A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease. Physostigmine Study GroupL J Thal, G Schwartz, M Sano, et al.
The Journal of Biological Chemistry|September 24, 2011
Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survivalNatsuko Tanabe, Benjamin D Wheal, Jiyun Kwon, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 20, 2011
Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancerLaura M Lashinger, Lauren M Malone, Graham W Brown, et al.
Pageof 120